Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROTI: Patient-reported outcomes after withdrawal from idebenone in Friedreich's ataxia
2010-023388-16Phase 3Completed
- Sponsor
- Santhera Pharmaceuticals
- Start
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Friedreich ataxia (FA) comparing Continuation of high-dose idebenone with Withdrawal to placebo (2 arms). Primary endpoint: Patient assessment of treatment assignment. Started Jan 2011; status: completed.
02
Drugs
idebenone
03
Conditions
Friedreich ataxia (FA)
Beyond the preview
Go deeper on 2010-023388-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023388-16.